The use of neoadjuvant lobar radioembolization prior to major hepatic resection for malignancy results in a low rate of post hepatectomy liver failure

BACKGROUND: Neoadjuvant yttrium-90 transarterial radioembolization (TARE) is increasingly being used as a strategy to facilitate resection of otherwise unresectable tumors due to its ability to generate both tumor response and remnant liver hypertrophy. Perioperative outcomes after the use of neoadj...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Gastrointest Oncol
Main Authors: Ahmed, Altan, Stauffer, John A., LeGout, Jordan D., Burns, Justin, Croome, Kristopher, Paz-Fumagalli, Ricardo, Frey, Gregory, Toskich, Beau
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107583/
https://ncbi.nlm.nih.gov/pubmed/34012663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-507
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares